SEC filingsOct 12, 2026 to Oct 19, 2026: insiders reported 840 purchases and sales across 212 companies.840 insider purchases and sales in 7 daysSee the filings →
HornScout

Company profile

PVLA

PALVELLA THERAPEUTICS, INC.
NASDAQHealth Care

Latest close: 120.30 USD · Oct 16, 2026 · 1 year · split-adjusted

On the price, the facts of the public record■Insider buy□Insider sell●Results filed
With an account, also○dividends▲splits◌next earningswith an account

End-of-day prices provided by Twelve Data · One close per session; the series does not update during the trading day.

Latest on record

The most recent facts, as filed.

Up to three of the most recent, checkable facts already loaded on this page, each linked to its source.

  1. Oct 14, 2026Reported sale · Form 4GEORGE M JENKINS · $57.7KOpen the filing ↗
  2. Oct 14, 2026Reported sale · Form 4GEORGE M JENKINS · $254.1KOpen the filing ↗
  3. Oct 14, 2026Reported sale · Form 4GEORGE M JENKINS · $321.0KOpen the filing ↗

In numbers

What this profile holds, counted.

Closes · 1 year250
SEC filings on record75218 flagged findings
Reported transactions (Form 4)80since Jun 10, 2025 · and 35 other holdings
Corporate events (8-K)30since May 21, 2021

What the record says

Description, identity and filings, each with its source.

Every block cites its source. The colour of a finding marks its category — which document, who filed it — not how much it matters.

Identity

Formerly traded as PIRS.

SEC topics

Regulatory history

Topics detected in its SEC reports, with the original excerpt.

Each topic is assigned by a classifier over the full filing; the excerpts show where it was detected and are not always enough to verify it. Open the filing to read it in full.

  • 2026-08-04share offering or dilution eventfreshOpen filing ↗
    “…Agreement”) with certain investors, including BVF Partners, L.P., an existing stockholder of Pieris (the “PIPE Investors”),…”
    +1 more passage from the same document
    • “…Warrant, which represents the per share purchase price of Common Stock less the $0.001 per share exercise price for each…”
  • 2026-08-04merger or acquisition eventfreshOpen filing ↗
    “…upon the consummation of the Merger (as defined below). On December 13, 2024 (the “Closing Date”), Palvella Therapeutics,…”
    +1 more passage from the same document
    • “…organizing and staffing the Company, business planning, raising capital and establishing its intellectual property portfolio. The…”

Original excerpts from SEC filings, untranslated. Not advice and not a prediction.

Reverse splits in 5 years

1 reverse split in 5 years (1:80 on Apr 23, 2024) · 1:80 cumulative

The other times: of 818 securities that did their first reverse split in 5 years, a year later the median was worth 0.53× the price on the day of the split; 382 lost more than half and 209 rose (809 with a price a year later).

Our own series, not the whole market: based on the splits we have on record (provider and SEC); an unrecorded one does not count. Historical distribution, not a prediction.

SEC record

SEC dossier

What this company has filed with the SEC, in plain language.

The 25 most recent filings (of 752)

Everything filed

Every SEC filing, newest first, with what it is. Below, each type with its own explanation.

752 filings on record, the oldest from Aug 20, 13.

Listing the 25 most recent filings of the 752 on record.

8-Ks, explained

Stress3Structure48Governance35
  • Governance3 senior executive changes2026show all 3hide
    • Jun 30, 26GovernanceA senior executive left or was appointed8-K 5.02 ↗
    • Jun 16, 26GovernanceA senior executive left or was appointed+2 more in the same filing8-K 5.02 ↗
    • Apr 13, 26GovernanceA senior executive left or was appointed8-K 5.02 ↗
  • Feb 26, 26StructureEntered a material agreement+1 more in the same filing8-K 1.01 ↗
  • Dec 16, 24StructureEntered a material agreement+10 more in the same filing8-K 1.01 ↗
  • Dec 12, 24GovernanceA senior executive left or was appointed+5 more in the same filing8-K 5.02 ↗
  • Aug 8, 24StructureEntered a material agreement+4 more in the same filing8-K 1.01 ↗
  • Jul 24, 24StructureEntered a material agreement+4 more in the same filing8-K 1.01 ↗
  • Jul 3, 24StructureA material agreement was terminated+2 more in the same filing8-K 1.02 ↗
  • Dec 21, 23StructureA material agreement was terminated+1 more in the same filing8-K 1.02 ↗
  • Aug 31, 23StressRestructuring plan with committed costs+1 more in the same filing8-K/A 2.05 ↗
  • Jul 18, 23StressRestructuring plan with committed costs+4 more in the same filing8-K 2.05 ↗
  • Jul 13, 23GovernanceA senior executive left or was appointed+1 more in the same filing8-K 5.02 ↗
  • Jun 26, 23GovernanceA senior executive left or was appointed+2 more in the same filing8-K 5.02 ↗

8 older filings not shown · The record reaches back to Dec 18, 14.

Notable in the record

Stress disclosures older than the timeline above. They are individual events from the record, not a complete timeline: there may be more between them.

The full record holds 3 stress filings.

Corporate events are tracked from 2004-08-23, when the SEC renumbered 8-K items. Earlier filings use an incompatible numbering and are not classified here.

Ownership and control

Schedule 13D: stake and stated purpose

Filed by holders above 5% of a share class who cannot use the short form. It includes the investor's stated purpose: read it before assuming they seek influence.

  • Kaupinen Wes14.6%Dec 13, 24SCHEDULE 13D ↗5 co-filers on this document — the figure is the largest single stake, not their sum.

Schedule 13G: short-form filing

The short form, for holders who meet specific requirements: institutional investors, passive investors without a control purpose, or exempt investors. Asset managers and index funds usually file it.

  • SUVRETTA CAPITAL MANAGEMENT, LLC7.4%Sep 30, 25SCHEDULE 13G/A ↗3 co-filers on this document — the figure is the largest single stake, not their sum.
  • PRUDENTIAL FINANCIAL INC6.7%Jun 30, 26SCHEDULE 13G ↗
  • Jennison Associates LLC6.7%Jun 30, 26SCHEDULE 13G ↗
  • James N. Topper6.3%Mar 31, 25SCHEDULE 13G/A ↗17 co-filers on this document — the figure is the largest single stake, not their sum. · 1 earlier filing
  • Frazier Life Sciences Public Fund, L.P.6.0%Dec 31, 25SCHEDULE 13G/A ↗14 co-filers on this document — the figure is the largest single stake, not their sum. · 1 earlier filing
show 5 more holdershide
  • BlackRock, Inc.5.7%Jun 30, 26SCHEDULE 13G ↗
  • First Light Asset Management, LLC5.3%Jun 30, 26SCHEDULE 13G/A ↗2 co-filers on this document — the figure is the largest single stake, not their sum. · 1 earlier filing
  • BVF PARTNERS L P/IL4.7%Jun 30, 26SCHEDULE 13G/A ↗10 co-filers on this document — the figure is the largest single stake, not their sum. · 2 earlier filings
  • Samsara BioCapital, L.P.3.1%Jun 30, 25SCHEDULE 13G/A ↗3 co-filers on this document — the figure is the largest single stake, not their sum.
  • Dellora Investments LP1.3%Dec 13, 24SCHEDULE 13G/A ↗3 co-filers on this document — the figure is the largest single stake, not their sum.

Structured 13D/G data starts 2023-12, when the SEC moved these filings to a machine-readable format. Earlier filings exist but are not parsed here.

Sale intention announced

On Oct 13, JENKINS GEORGE M filed notice of intent to sell up to $3.7M. That is about 0.19% of shares outstanding. It is filed under a scheduled plan (10b5-1), arranged in advance.

A notice is not a sale: it may not go ahead, may happen in part, or at a different price.

After the notice, they sold $1.8M across 12 trades, between Oct 13 and Oct 14, per their Form 4. That is 52% of the shares announced so far, and the window is still open.

View notice (Form 144) ↗+5 more recent notices · 5 with a later sale

SEC record

Insider transactions

Buys and sells reported by officers, directors and major shareholders on SEC Form 4.

Buys and sells

  • Oct 14, 26Sell$58KGEORGE M JENKINS↗
  • Oct 14, 26Sell$254KGEORGE M JENKINS↗
  • Oct 14, 26Sell$321KGEORGE M JENKINS↗
  • Oct 14, 26Sell$114KGEORGE M JENKINS↗
  • Oct 14, 26Sell$75KGEORGE M JENKINS↗
  • Oct 14, 26Sell$64KGEORGE M JENKINS↗
  • Oct 13, 26Sell$258KGEORGE M JENKINS↗
  • Oct 13, 26Sell$212KGEORGE M JENKINS↗
  • Oct 13, 26Sell$129KGEORGE M JENKINS↗
  • Oct 13, 26Sell$136KGEORGE M JENKINS↗
  • Oct 13, 26Sell$77KGEORGE M JENKINS↗
  • Oct 13, 26Sell$123KGEORGE M JENKINS↗

There are 23 more transactions in this stretch.

Stock compensation, tax and giftsshow the 5 other transactionshide

Stock compensation, tax withholding, option exercises and gifts. They are listed separately and are not included in the purchase and sale totals. The type describes the transaction, not the filer's intent.

  • Sep 16, 26Compensation$15KKathleen GoinChief Operating Officer↗
  • Sep 16, 26Compensation$20KKathleen GoinChief Operating Officer↗
  • Sep 2, 26Compensation$40KCHRISTOPHER P KIRITSY↗
  • Aug 19, 26Compensation$15KKathleen GoinChief Operating Officer↗
  • Aug 19, 26Compensation$20KKathleen GoinChief Operating Officer↗

The full record holds 99 transactions and goes back to Feb 24, 23.

Its sector and its market

PALVELLA THERAPEUTICS, INC. among Health Care companies

The profile shows what is on record. Context and Radar place the company among those of its sector and region.

With an account you also get

  • The four engines — growth, trend, risk and context — each with its word and its score.
  • The risk band and the sector phase.
  • The company's fundamentals and accounts.
  • Watchlist: your list of companies, with the «since you follow it» figure.

The research continues

The profile tells the story. The market sets the scene.

From PALVELLA THERAPEUTICS, INC., the path continues in the other areas. Each one is shown with its own example, named in its step.

  1. Place it in its market

    Seven layers of its region's market — rates, credit, stress, liquidity, regime, breadth and sectors — with historical precedents. Public example: Apple and ASML.

    See how Context works →
  2. See what deserves a closer look

    Every morning Radar screens the covered companies through a lens and explains why each candidate made the list. Public example: the lists from Aug 11, 2026.

    See how Radar works →
  3. Keep the why

    Follow PALVELLA THERAPEUTICS, INC. in the Watchlist and review what changed since you added it: context, notices and filings. Written theses are coming soon. Public example: Apple.

    See an example review →

Coverage

What sits behind this page.

Where each figure comes from and how far it reaches.

Prices
End-of-day closes provided by Twelve Data. One close per session; not real time. Closes adjusted for splits.
Series quality
250 clean closes in the period.
SEC records
752 documents on file, from Aug 20, 2013 to Oct 14, 2026.
Company description
No description available.
This page
Generated on Oct 19, 2026; refreshed through the day.

Start at your own pace

Explore first. Go deeper with access.

Every company's public profile is open. The full reading — context, Radar, watchlist — is inside, in an invitation-only beta.

Compare plans →
  • No account

    This profile for every company we cover: closing prices with the record's facts on the curve, the SEC file in plain language, insider trades included, and links to its sector and exchange.

  • Pro

    What matters today, with its reason, is free with an account. Pro adds, in the profile, each company's notices and their explanation and the analysis of its insiders; in Radar, all the lenses, which notice each candidate carries, filters by notice type and «no dilution», and the cycle cohort filter; and in Watchlist, more companies and notice changes with their reason.

  • Pro+

    Adds the Lab: test a hypothesis on comparable cohorts before reusing it; and bring your lenses to Radar.

Are the prices real time?

No. It is one close per session, from the provider and with the date shown on the profile; it does not update during the trading day.

Which SEC documents appear here?

Those filed with the SEC by the company, its insiders and its major shareholders, within our coverage: periodic reports (10-K, 10-Q, 20-F), material events (8-K), proposed sale notices (Form 144), insider transactions (Form 4) and stakes above 5% (13D/13G). Each links to the original on EDGAR.

Why does a European company show no SEC records?

It depends on the company: some European issuers file a 20-F or 6-K with the SEC and others don't. The profile shows whatever is on record; when there is nothing, it says so rather than guessing why. Europe does not yet have a common filing archive like EDGAR in the United States. The EU will open its own, ESAP, in July 2027 (managers' transactions arrive in January 2028), and we plan to add it once it is available.

Before forming a view on a company,
read what is on record.

One close per session. The record in plain language. Its sector and its market one link away. Your judgment when deciding.

Access by invitation while the beta lasts. Not advice: the profile shows what is on record; it does not recommend.